{"id":40611,"date":"2020-01-13T13:58:52","date_gmt":"2020-01-13T21:58:52","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/13\/gw-pharma-beats-projections-with-108m-in-q4-sales-thanks-to-cbd-drug\/"},"modified":"2020-01-14T00:36:29","modified_gmt":"2020-01-14T08:36:29","slug":"gw-pharma-beats-projections-with-108m-in-q4-sales-thanks-to-cbd-drug","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/13\/gw-pharma-beats-projections-with-108m-in-q4-sales-thanks-to-cbd-drug\/","title":{"rendered":"GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug"},"content":{"rendered":"<\/p>\n<p>A popular cannabis-derived epilepsy treatment is\u00a0increasing sales\u00a0for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company\u2019s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed the sales figures to physicians [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/gw-pharma-beats-analyst-projections-with-108m-in-q4-sales-thanks-to-cbd-drug\/\">GW Pharma beats projections with $108M in Q4 sales thanks to CBD drug<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/gw-pharma-beats-analyst-projections-with-108m-in-q4-sales-thanks-to-cbd-drug\/\" target=\"_blank\">GW Pharma beats projections with 8M in Q4 sales thanks to CBD drug<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A popular cannabis-derived epilepsy treatment is\u00a0increasing sales\u00a0for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019. The company\u2019s fourth-quarter sales beat consensus analyst expectations of $102.4 million. GW attributed<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/13\/gw-pharma-beats-projections-with-108m-in-q4-sales-thanks-to-cbd-drug\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9662,3156,9664,3157,2786,4613,9663],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40611"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=40611"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40611\/revisions"}],"predecessor-version":[{"id":40612,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40611\/revisions\/40612"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=40611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=40611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=40611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}